Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Pliant Therapeutics, Inc. (PLRX) had Income from Continuous Operations of $-26.30M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-26.30M |
|
-- |
|
-- |
|
$28.27M |
|
$-28.27M |
|
$1.97M |
|
$-26.30M |
|
$-26.30M |
|
$-26.30M |
|
|
Income from Continuous Operations |
$-26.30M |
$-26.30M |
|
$-26.30M |
|
$-28.27M |
|
$-27.50M |
|
61.41M |
|
61.41M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$245.59M |
|
$4.34M |
|
$31.01M |
|
$276.60M |
|
$17.62M |
|
$30.44M |
|
$58.67M |
|
$76.29M |
|
$200.31M |
|
$200.31M |
|
$200.31M |
|
61.45M |
|
| Cash Flow Statement Financials | |
$-110.55M |
|
$132.52M |
|
$0.57M |
|
$72.67M |
|
$95.21M |
|
$22.54M |
|
$21.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.93 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-110.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.13% |
|
-13.13% |
|
-9.51% |
|
-11.40% |
|
$3.26 |
|
$-1.80 |
|
$-1.80 |
|